Lactylation of PD-L1 by a lactyltransferase HAT1 dictates its protein stability and tumor immune evasion
Proceedings of the National Academy of Sciences · 02.06.2026 · 123 (22)
DOI: 10.1073/pnas.2537490123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 27.05.2026. Verfasst von Man Shang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Women's Hospital of Nanjing Medical University (Nanjing Women and Children's Healthcare Hospital), Nanjing 210004, China. Hauptthemen laut MEDLINE: B7-H1 Antigen, Histone Acetyltransferases, Tumor Escape. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Key R&D Program of China, MOE | Fundamental Research Funds for the Central Universities (Fundamental Research Fund for the Central Universities).
Abstract (Originalsprache)
Lysine lactylation regulates protein fate and function across diverse biological processes. While PD-L1 has been widely studied posttranslationally, the role of its lactylation and the responsible enzyme have remained poorly studied. Here, we identify histone acetyltransferase 1 (HAT1) as a lactyltransferase that catalyzes programmed cell death ligand 1 (PD-L1) lactylation at residues K75 and K178 within its extracellular domain, thereby enhancing PD-L1 stability. Mechanistically, this glycosylation-dependent modification protects PD-L1 from endoplasmic reticulum (ER)-associated degradation and promotes ER-to-Golgi trafficking. Targeting PD-L1 lactylation by HAT1 knockdown, mutation of the lactylation sites or HAT1-PD-L1-interferring peptides suppresses tumor progression and enhances anti-PD-1 therapy efficacy. Clinically, lactylated PD-L1 strongly correlates with tumor progression. Together, these findings establish HAT1-mediated PD-L1 lactylation as a key mechanism of immune evasion and suggest that targeting this pathway could improve cancer immunotherapy outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, Women's Hospital of Nanjing Medical University (Nanjing Women and Children's Healthcare Hospital), Nanjing 210004, China.
- Zhongda Hospital, School of Life Sciences and Technology, Advanced Institute for Life and Health, Southeast University, Nanjing 210096, China.
- Nanjing Medical Key Laboratory of Female Fertility Preservation and Restoration, Nanjing 210004, China.
- Medical College, Guizhou University, Guiyang 550025, China.
- Innovative Vaccine and Immunotherapy Research Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
- State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Women and Children's Healthcare Institute, Biobank, and Cell Therapy Center, Women's Hospital of Nanjing Medical University, (Nanjing Women and…
ORCID-Profile: Xujie Zhao, Xiaohui Yang, Ya Wen, Xiaofeng Zhu, Shuguang Tan, Chenbo Ji, Shan Gao
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- National Key R&D Program of China
- MOE | Fundamental Research Funds for the Central Universities (Fundamental Research Fund for the Central Universities)
- Start-up Research Fund of Southeast University
- JST | Jiangsu Natural Science Foundation | Basic Research Program of Jiangsu Province
- JST | Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation)
- Nanjing Postdoctoral Research Grant
- China Postdoctoral Science Foundation ()
Zitieren
APA
Shang, M., Zhao, X., Zhang, Y., Zhang, C., Yang, X., Wen, Y., Zhu, X., Chen, Y., Gu, Y., Pan, Y., Jiang, S., Tan, S., Jia, X., Ji, C., & Gao, S. (2026). Lactylation of PD-L1 by a lactyltransferase HAT1 dictates its protein stability and tumor immune evasion. Proceedings of the National Academy of Sciences, 123(22). https://doi.org/10.1073/pnas.2537490123
Vancouver
Shang M, Zhao X, Zhang Y, Zhang C, Yang X, Wen Y, et al. Lactylation of PD-L1 by a lactyltransferase HAT1 dictates its protein stability and tumor immune evasion. Proceedings of the National Academy of Sciences. 2026;123(22). doi:10.1073/pnas.2537490123
BibTeX
@article{Shang2026,
author = {Shang, Man and Zhao, Xujie and Zhang, Yibi and Zhang, Chang and Yang, Xiaohui and Wen, Ya and Zhu, Xiaofeng and Chen, Yiwen and Gu, Yinmin and Pan, Yongbo and Jiang, Siyuan and Tan, Shuguang and Jia, Xuemei and Ji, Chenbo and Gao, Shan},
title = {Lactylation of PD-L1 by a lactyltransferase HAT1 dictates its protein stability and tumor immune evasion},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {22},
doi = {10.1073/pnas.2537490123}
}
EUVIMED